1-7 of 7
Howard L. Parnes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts

Elizabeth A. Platz, Ibrahim Kulac, John R. Barber, Charles G. Drake, Corinne E. Joshu, William G. Nelson, M. Scott Lucia, Eric A. Klein, Scott M. Lippman, Howard L. Parnes, Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, Angelo M. De Marzo
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2017) 26 (10): 1549–1557.
https://doi.org/10.1158/1055-9965.EPI-17-0503
Published: 01 October 2017
View article titled, A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts
Open the PDF for A Prospective Study of Chronic Inflammation in Benign Prostate Tissue and Risk of Prostate Cancer: Linked PCPT and SELECT Cohorts in another window
Includes: Supplementary data
Journal Articles

Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial

Teemu J. Murtola, Bora Gurel, Martin Umbehr, M. Scott Lucia, Ian M. Thompson, Jr, Phyllis J. Goodman, Alan R. Kristal, Howard L. Parnes, Scott M. Lippman, Siobhan Sutcliffe, Sarah B. Peskoe, John R. Barber, Charles G. Drake, William G. Nelson, Angelo M. De Marzo, Elizabeth A. Platz
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2016) 25 (3): 463–469.
https://doi.org/10.1158/1055-9965.EPI-15-0987
Published: 03 March 2016
View article titled, Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial
Open the PDF for Inflammation in Benign Prostate Tissue and Prostate Cancer in the Finasteride Arm of the Prostate Cancer Prevention Trial in another window
Journal Articles

Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

Sarah H. Nash, Cathee Till, Xiaoling Song, M. Scott Lucia, Howard L. Parnes, Ian M. Thompson, Jr, Scott M. Lippman, Elizabeth A. Platz, Jeannette Schenk
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2015) 24 (10): 1507–1515.
https://doi.org/10.1158/1055-9965.EPI-15-0394
Published: 30 September 2015
View article titled, Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Open the PDF for Serum Retinol and Carotenoid Concentrations and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial in another window
Journal Articles

Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial

Alan R. Kristal, Cathee Till, Xiaoling Song, Catherine M. Tangen, Phyllis J. Goodman, Marian L. Neuhauser, Jeannette M. Schenk, Ian M. Thompson, Frank L. Meyskens, Jr, Gary E. Goodman, Lori M. Minasian, Howard L. Parnes, Eric A. Klein
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2014) 23 (8): 1494–1504.
https://doi.org/10.1158/1055-9965.EPI-14-0115
Published: 31 July 2014
View article titled, Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial
Open the PDF for Plasma Vitamin D and Prostate Cancer Risk: Results from the Selenium and Vitamin E Cancer Prevention Trial in another window
Journal Articles

Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

Bora Gurel, M. Scott Lucia, Ian M. Thompson, Jr, Phyllis J. Goodman, Catherine M. Tangen, Alan R. Kristal, Howard L. Parnes, Ashraful Hoque, Scott M. Lippman, Siobhan Sutcliffe, Sarah B. Peskoe, Charles G. Drake, William G. Nelson, Angelo M. De Marzo, Elizabeth A. Platz
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2014) 23 (5): 847–856.
https://doi.org/10.1158/1055-9965.EPI-13-1126
Published: 01 May 2014
View article titled, Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Open the PDF for Chronic Inflammation in Benign Prostate Tissue Is Associated with High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial in another window
Journal Articles

Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial

Elizabeth A. Platz, Cathee Till, Phyllis J. Goodman, Howard L. Parnes, William D. Figg, Demetrius Albanes, Marian L. Neuhouser, Eric A. Klein, Ian M. Thompson, Jr., Alan R. Kristal
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2009) 18 (11): 2807–2813.
https://doi.org/10.1158/1055-9965.EPI-09-0472
Published: 08 November 2009
View article titled, Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial
Open the PDF for Men with Low Serum Cholesterol Have a Lower Risk of High-Grade Prostate Cancer in the Placebo Arm of the Prostate Cancer Prevention Trial in another window
Includes: Supplementary data
Journal Articles

Phase III bladder cancer chemoprevention trial with fenretinide.

Anita L. Sabichi, Seth P. Lerner, E. Neely Atkinson, H. Barton Grossman, Nancy P. Caraway, Ruth L. Katz, David F. Penson, Colin P. Dinney, Surena F. Matin, Ashish Kamat, Louis L. Pisters, Dean E. Brenner, John L. Clifford, Howard L. Parnes, Scott M. Lippman
Journal: Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiol Biomarkers Prev (2006) 15 (12_Supplement): A148.
Published: 01 December 2006
View article titled, Phase III bladder cancer chemoprevention trial with fenretinide.